We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$995M
AUM Growth
+$63.9M
Cap. Flow
+$40.8M
Cap. Flow %
4.1%
Top 10 Hldgs %
15.14%
Holding
1,060
New
134
Increased
450
Reduced
317
Closed
75

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$1.72M
2
FIVE icon
Five Below
FIVE
+$1.59M
3
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$1.22M
4
PWS icon
Pacer WealthShield ETF
PWS
+$1.18M
5
MSFT icon
Microsoft
MSFT
+$1.13M

Top Sells

Rank Stock Value
1
PAR icon
PAR Technology
PAR
+$1.67M
2
AWK icon
American Water Works
AWK
+$1.26M
3
BOND icon
PIMCO Active Bond Exchange-Traded Fund
BOND
+$1.08M
4
WSO icon
Watsco Inc
WSO
+$1.04M
5
DD icon
DuPont de Nemours
DD
+$766K

Sector Composition

Rank Sector Weight
1 Technology 12.73%
2 Financials 9.55%
3 Healthcare 8.91%
4 Consumer Discretionary 8.6%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHK
926
DELISTED
Chesapeake Energy Corporation
CHK
$47K ﹤0.01%
121
-7
-5% -$3.5K
PIXY
927
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
– –
0
– –
GNW icon
928
Genworth Financial
GNW
$3.8B
$43K ﹤0.01%
11,500
– –
TARA icon
929
Protara Therapeutics
TARA
$226M
$43K ﹤0.01%
2,600
+1,125
+76% +$19.9K
GNCA
930
DELISTED
Genocea Biosciences, Inc.
GNCA
$43K ﹤0.01%
+11,000
New +$57.4K
DVAX
931
DELISTED
Dynavax Technologies
DVAX
$42K ﹤0.01%
+10,500
New +$60.9K
RGLS
932
DELISTED
Regulus Therapeutics
RGLS
$42K ﹤0.01%
3,338
-1,011
-23% -$11.6K
UAN icon
933
CVR Partners
UAN
$1.3B
$41K ﹤0.01%
1,013
– –
PLX icon
934
Protalix BioTherapeutics
PLX
$191M
$40K ﹤0.01%
+8,500
New +$35.9K
CLDX icon
935
Celldex Therapeutics
CLDX
$2.77B
$36K ﹤0.01%
+13,356
New +$45.4K
RUHN
936
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
$36K ﹤0.01%
+10,400
New +$53.4K
YOGA
937
DELISTED
YogaWorks, Inc. Common Stock
YOGA
$36K ﹤0.01%
60,825
+13,799
+29% +$11.4K
SEEL
938
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$35K ﹤0.01%
+4
New +$42.1K
CYTO
939
DELISTED
Altamira Therapeutics Ltd
CYTO
$35K ﹤0.01%
31
+10
+48% +$17.4K
LTRX icon
940
Lantronix
LTRX
$236M
$33K ﹤0.01%
+10,000
New +$34.4K
TCON
941
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$32K ﹤0.01%
+238
New +$37.6K
NIO icon
942
NIO
NIO
$11.3B
$29K ﹤0.01%
11,400
-5,450
-32% -$21.9K
NOG icon
943
Northern Oil and Gas
NOG
$2.3B
$27K ﹤0.01%
+1,424
New +$32.9K
CRDF icon
944
Cardiff Oncology
CRDF
$64.3M
$25K ﹤0.01%
+10,070
New +$32.3K
EFOI icon
945
Energy Focus
EFOI
$18.3M
$25K ﹤0.01%
1,743
– –
ATYR
946
aTyr Pharma
ATYR
$46.4M
$25K ﹤0.01%
4,805
+2,948
+159% +$20K
CPAH
947
DELISTED
Counterpath Corp
CPAH
$25K ﹤0.01%
16,318
-9,682
-37% -$16K
SRRA
948
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$22K ﹤0.01%
985
-113
-10% -$5.47K
HL icon
949
Hecla Mining
HL
$10.2B
$20K ﹤0.01%
11,104
+103
+0.9% +$189
ZVRA icon
950
Zevra Therapeutics
ZVRA
$563M
$20K ﹤0.01%
726
-1,978
-73% -$49.7K
36 37
38
39 40

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q2 2019 Portfolio in Review

As of Q2 2019, Wedbush Securities held 1,060 positions worth $995M, up 6.9% from $931M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Wedbush Securities deployed $40.8M of net new capital in Q2 2019, opening 134 new positions and adding to 450 existing holdings. Its largest new stake was Pacer WealthShield ETF: 48,221 shares worth $1.17M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was PAR Technology, an estimated $1.67M trimmed.

  • Wedbush Securities's largest Q2 2019 buy was Pacer WealthShield ETF: 48,221 shares worth $1.17M.
  • Wedbush Securities added most to Walt Disney in Q2 2019, an estimated $1.72M increase.
  • Wedbush Securities's biggest Q2 2019 reduction was PAR Technology, cutting an estimated $1.67M.
  • Wedbush Securities fully exited PIMCO Active Bond Exchange-Traded Fund in Q2 2019, selling an estimated $1.08M.
  • Wedbush Securities's ten largest holdings make up 15% of its $995M portfolio in Q2 2019.
  • Wedbush Securities opened 134 new positions and closed 75 in Q2 2019.
  • Wedbush Securities's portfolio value rose 6.9% quarter-over-quarter to $995M.

Based on Wedbush Securities's 13F filing for Q2 2019, filed 1 Aug 2019.